FromAstraZeneca ([email protected])
Subject (117)Fasenra recommended for approval in the EU by CHMP for the treatment of eosinophilic granulomatosis with polyangiitis
Preheader (117)Fasenra recommended for approval in the EU by CHMP for the treatment of eosinophilic granulomatosis with polyangiitis
Typography
Arial
Colors
Text Analysis
Body Words254
Subject Words17
Body Emojis1
Subject Emojis
Media Analysis
Text Links9
Image Links4
Total Links13
Images7
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px984 px
X-Spam Score-0.2
Preheader OptimizedNo
Timing
Day of WeekFriday
TimeEvening

Fasenra recommended for approval in the EU by CHMP for the treatment of eosinophilic granulomatosis with polyangiitis

Fasenra recommended for approval in the EU by CHMP for the treatment of eosinophilic granulomatosis with polyangiitis
Fasenra recommended for approval in the EU by CHMP for the treatment of eosinophilic granulomatosis with polyangiitis